SK Chemicals and IVI sign MOU on Typhoid Vaccine

Media Release: SK Chemicals and International Vaccine Institute sign MOU on Typhoid Vaccine Development and Supply
Seoul, October 9, 2012

Under the terms of the MOU, SK Chemicals and IVI will exchange their technology for the development of a Typhoid vaccine and will collaborate on future clinical studies and application for the prequalification from the WHO. SK Chemicals will manufacture and supply about 10 million doses of the Typhoid vaccine to developing countries through the United Nations Children’s Fund (UNICEF).

More at: http://www.ivi.org/web/www/07_01?p_p_id=EXT_BBS&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_EXT_BBS_struts_action=%2Fext%2Fbbs%2Fview_message&_EXT_BBS_messageId=465